PIM1 and oral cavity carcinoma: In a study of 36 patients with oral cavity carcinomas treated with surgery, Chiang et al. [15] found that patients with elevated PIM-1 expression at transcriptional or immunohistochemical level had worse survival, but the differences did not reach statistical significance.